Tag: biopharma
Parexel appoints Gwyn Bebb to lead oncology clinical development
In this role Dr Bebb will lead the research and development of new cancer treatments for biopharmaceutical customers worldwide
BioVoice eMagazine September 2023 | Issue 9 | Volume 4
The Cover Story decodes the smart hospital concept and the latest trends on adoption of automation and digitalization within Indian hospitals. Read the series of power-packed interviews featuring leading industry figures, Subodh Gupta of Lord’s Mark Microbiotech; Ajaykumar JK of Vellon Space, Anantha Nema of Veeva Systems, Dr Sabahat S. Azim of Glocal Healthcare; & Rajnikant Shah of Medtech Life.
Biopharmaceuticals packaging market to reach US$ 44 billion by 2030: Report
Anticipated to accumulate a market value of US$ 18.87 billion in 2023, the biopharmaceutical packaging market reflected a growth of 7% CAGR in the historical period 2018 to 2022
G20 Summit 2023: Takeda emphasizes diversity, equity & inclusion as essential...
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Sathgen Therapeutics completes dosing of first two cohorts of healthy volunteers...
MSP008-22 is a new drug candidate showing excellent efficacy against viruses during preclinical development
Cipla launches CiplaMed 2.0 – knowledge-sharing platform for healthcare practitioners
CiplaMed 2.0 leverages advanced analytics and automation, which have the potential to transform knowledge-sharing in the pharmaceutical industry
BioVoice eMagazine August 2023 | Issue 8 | Volume 4
The current issue discusses both approved and pending bills related to bioscience sector in the Parliament. It features the power-packed interviews with Krishna Mohan Puvvada, Vice President, Novozymes-South Asia; Dr Radha Rangarajan, Director, Central Drug Research Institute; Vikram Thaploo, CEO-Telehealth, Apollo Hospitals; and Vaibhav Tewari, Co-founder & CEO, Portea Medical.
Preventing the Next Global Pandemic
Antibiotic resistance and the associated spread of untreatable ‘superbugs’ is one of the major public health concerns of the 21st century
CEPI to provide US$3.6 million fund for self-amplifying mRNA vaccine technology...
Funding will support optimisation of Gennova Biopharmaceutical's technology platform to enhance immunogenicity
India’s promising CRO story
Post pandemic, Indian Contract Research Organizations have re-engineered their resources to tap the increasing demand from North America and Europe, writes Dr Kiran Marthak